Senapati, Jayastu
Jabbour, Elias http://orcid.org/0000-0003-4465-6119
Kantarjian, Hagop http://orcid.org/0000-0002-1908-3307
Short, Nicholas J. http://orcid.org/0000-0002-2983-2738
Funding for this research was provided by:
K12 Paul Calabresi Clinical Oncology Scholar Award American Society of Hematology Junior Faculty Scholar Award in Clinical Research.
Article History
Received: 22 August 2022
Revised: 11 October 2022
Accepted: 14 October 2022
First Online: 29 October 2022
Competing interests
: EJ received research grants from Abbvie, Adaptive biotechnologies, Amgen, Pfizer, and Takeda; and consultancy fees from Abbvie, adaptive biotechnologies, Amgen, BMS, Genentech, Incyte, Novartis, Pfizer, and Takeda. HK has received research grants from AbbVie, Agios, Amgen, Ariad, Astex, BMS, Cyclacel, Daiichi-Sankyo, Immunogen, Jazz Pharma, Novartis, Pfizer, Actinium, and Takeda. NJS has served as consultant for Takeda Oncology, Pfizer, Jazz Pharmaceuticals, and Sanofi, reports receiving research grants from Takeda Oncology, Astellas Pharma Inc., Stemline and Xencor, and has received honoraria from Amgen, Astellas Pharma Inc., and Sanofi.